Acumen Pharmaceuticals, Inc. layoffs
Yes. Acumen Pharmaceuticals, Inc. has filed 1 SEC 8-K with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Nov 5, 2026, described about 52 job cuts.
Check ABOS layoff riskSEC filings since 2023
- Nov 52026
Acumen Pharmaceuticals to cut about 52 jobs
Acumen Pharmaceuticals, Inc. (ABOS) · filed 5 days agoAs previously disclosed in its Current Report on Form 8-K filed on October 30, 2026, the Company announced that it plans to cease development of sabirnetug, including the open-label extension portion of its ALTITUDE-AD trial, and to evaluate its strategic options, including with respect to its Enhanced Brain Delivery™ (EBD ® ) program.
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.